Neurocrine Biosciences, Inc.
DE ˙ DB ˙ US64125C1099
134,65 € ↑0,30 (0,22%)
2026-06-03
DEL PRIS
SecurityDE:NB3 / Neurocrine Biosciences, Inc.
InstitutionUBS Group AG
Latest Disclosed Ownership1,221,036 shares
Latest Disclosed Value $ 160,859,283
UBS Group AG ownership in NB3 / Neurocrine Biosciences, Inc.

On May 5, 2026 - UBS Group AG filed a 13F-HR form disclosing ownership of 1,221,036 shares of Neurocrine Biosciences, Inc. (DE:NB3) valued at $136,450,773 USD as of March 31, 2026. The entity filed a previous 13F-HR on January 29, 2026 disclosing 983,528 shares of Neurocrine Biosciences, Inc.. This represents a change in shares of 24.15% during the quarter. The current value of the position is $164,412,497 USD.

UBS Group AG has a history of taking positions in derivatives of the underlying security (NB3) in the form of stock options. The firm currently holds call options representing 0 of underlying shares valued at $0 USD and put options representing 0 of underlying shares valued at $0 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

DE:NB3 / Neurocrine Biosciences, Inc. Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-05 2026-03-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 1,221,036 237,508 24.15 160,859 15.32 0.0045
2026-01-29 2025-12-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 983,528 618,956 169.78 139,494 172.56 0.0226
2025-11-13 2025-09-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 364,572 -237,553 -39.45 51,179 -32.38 0.0080
2025-08-14 2025-06-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 602,125 -183,376 -23.35 75,681 -12.89 0.0131
2025-05-13 2025-03-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 785,501 366,073 87.28 86,876 51.75 0.0160
2025-02-14 2024-12-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 419,428 59,859 16.65 57,252 38.19 0.0106
2024-11-14 2024-09-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 359,569 42,642 13.45 41,430 -5.05 0.0090
2024-08-14 2024-06-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 316,927 81,301 34.50 43,631 34.26 0.0108
2024-05-13 2024-03-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 235,626 91,732 63.75 32,498 71.41 0.0081
2024-02-09 2023-12-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 143,894 9,655 7.19 18,959 25.55 0.0057
2023-11-09 2023-09-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 134,239 10,938 8.87 15,102 29.88 0.0052
2023-08-11 2023-06-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 123,301 -1,325 -1.06 11,627 -7.82 0.0039
2023-05-12 2023-03-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 124,626 -92,172 -42.52 12,615 -51.29 0.0046
2023-02-08 2022-12-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 216,798 64,678 42.52 25,894 60.27 0.0097
2022-11-10 2022-09-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 152,120 68,323 81.53 16,156 97.77 0.0071
2022-08-10 2022-06-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 83,797 -141,449 -62.80 8,169 -61.32 0.0034
2022-05-16 2022-03-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 225,246 -610 -0.27 21,117 9.78 0.0070
2022-02-14 2021-12-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 225,856 54,141 31.53 19,236 16.79 0.0055
2021-11-15 2021-09-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 171,715 30,328 21.45 16,470 19.69 0.0052
2021-08-13 2021-06-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 141,387 49,514 53.89 13,760 54.00 0.0044
2021-05-12 2021-03-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 91,873 76,245 487.87 8,935 496.06 0.0030
2021-02-11 2020-12-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 15,628 -557 -3.44 1,499 -3.73 0.0005
2020-11-12 2020-09-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 16,185 -43,031 -72.67 1,557 -78.45 0.0006
2020-07-31 2020-06-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 59,216 9,120 18.21 7,225 66.63 0.0031
2020-05-01 2020-03-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 50,096 -24,952 -33.25 4,336 -46.25 0.0020
2020-02-14 2019-12-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 75,048 -29,711 -28.36 8,067 -14.54 0.0028
2019-11-14 2019-09-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 104,759 73,000 229.86 9,440 252.11 0.0036
2019-08-14 2019-06-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 31,759 -11,859 -27.19 2,681 -30.24 0.0010
2019-05-14 2019-03-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 43,618 -104,174 -70.49 3,843 -63.58 0.0016
2019-02-14 2018-12-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 147,792 105,626 250.50 10,553 103.57 0.0048
2018-11-14 2018-09-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 42,166 31,256 286.49 5,184 383.58 0.0021
2018-08-14 2018-06-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 10,910 -50,319 -82.18 1,072 -78.89 0.0005
2018-05-15 2018-03-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 61,229 37,618 159.32 5,077 177.13 0.0022
2018-02-14 2017-12-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 23,611 21 0.09 1,832 26.69 0.0008
2017-11-14 2017-09-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 23,590 -10,962 -31.73 1,446 -9.00 0.0007
2017-11-14 2017-06-30 13F/A-1 NEUROCRINE BIOSCIENCES COM 64125C109 34,552 -9,910 -22.29 1,589 -17.45 0.0008
2017-08-14 2017-06-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 34,552 -9,910 1,589
2017-11-14 2017-03-31 13F/A-1 NEUROCRINE BIOSCIENCES COM 64125C109 44,462 -212 -0.47 1,925 11.34 0.0011
2017-05-12 2017-03-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 44,462 -212 1,925
2017-02-14 2016-12-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 44,674 -21,517 -32.51 1,729 -48.42 0.0010
2016-11-14 2016-09-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 66,191 -79,423 -54.54 3,352 -49.35 0.0020
2016-08-12 2016-06-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 145,614 110,364 313.09 6,618 374.75 0.0042
2016-05-12 2016-03-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 35,250 -19,270 -35.34 1,394 -54.81 0.0009
2016-02-16 2015-12-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 54,520 38,426 238.76 3,085 381.28 0.0020
2015-11-13 2015-09-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 16,094 59 0.37 641 -16.32 0.0005
2015-08-14 2015-06-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 16,035 4,322 36.90 766 64.38 0.0005
2015-05-14 2015-03-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 11,713 -13,447 -53.45 466 -17.08 0.0003
2015-02-17 2014-12-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 25,160 25,160 562 0.0004
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2025-11-13 2025-09-30 13F NEUROCRINE BIOSCIENCES COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2025-08-14 2025-06-30 13F NEUROCRINE BIOSCIENCES COM Call 12,400 1,559 n/a n/a n/a
2020-07-31 2020-06-30 13F NEUROCRINE BIOSCIENCES COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2020-05-01 2020-03-31 13F NEUROCRINE BIOSCIENCES COM Call 40,000 3,462 n/a n/a n/a
2019-11-14 2019-09-30 13F NEUROCRINE BIOSCIENCES COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2019-08-14 2019-06-30 13F NEUROCRINE BIOSCIENCES COM Call 27,400 -2.49 2,313 -6.58 n/a n/a n/a
2019-05-14 2019-03-31 13F NEUROCRINE BIOSCIENCES COM Call 28,100 2,476 n/a n/a n/a
2016-05-12 2016-03-31 13F NEUROCRINE BIOSCIENCES COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2016-02-16 2015-12-31 13F NEUROCRINE BIOSCIENCES COM Call 100 0.00 6 50.00 n/a n/a n/a
2015-11-13 2015-09-30 13F NEUROCRINE BIOSCIENCES COM Call 100 -99.92 4 -99.93 n/a n/a n/a
2015-08-14 2015-06-30 13F NEUROCRINE BIOSCIENCES COM Call 123,900 50.00 5,917 80.40 n/a n/a n/a
2015-05-14 2015-03-31 13F NEUROCRINE BIOSCIENCES COM Call 82,600 -65.61 3,280 -38.87 n/a n/a n/a
2015-02-17 2014-12-31 13F NEUROCRINE BIOSCIENCES COM Call 240,200 5,366 n/a n/a n/a
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2022-11-10 2022-09-30 13F NEUROCRINE BIOSCIENCES COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2022-08-10 2022-06-30 13F NEUROCRINE BIOSCIENCES COM Put 72,000 0.00 7,019 3.99 n/a n/a n/a
2022-05-16 2022-03-31 13F NEUROCRINE BIOSCIENCES COM Put 72,000 -17.05 6,750 -8.70 n/a n/a n/a
2022-02-14 2021-12-31 13F NEUROCRINE BIOSCIENCES COM Put 86,800 2,070.00 7,393 1,825.26 n/a n/a n/a
2021-11-15 2021-09-30 13F NEUROCRINE BIOSCIENCES COM Put 4,000 384 n/a n/a n/a
2015-05-14 2015-03-31 13F NEUROCRINE BIOSCIENCES COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2015-02-17 2014-12-31 13F NEUROCRINE BIOSCIENCES COM Put 53,300 1,191 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.